TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034 — FDA record Z-1310-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Apr 26, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034
Reason
Due to a shift in the citrated blood reference range for a normal population, the ranges stated in the IFU are changing. If the clinician relies solely on affected results in comparison to the normal donor reference range, it could lead to misdiagnosis and incorrect treatment or failure to treat.
Classification
Class II
Recalling firm
Haemonetics Corporation
Quantity
3933 kits (US); 2429 kits (OUS)
Agency-reported status
Terminated
Source record identifier
Z-1310-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI-DI: (01)20812747018095 All lots are affected.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Domestic distribution US Nationwide.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Jul 6, 2022
Recall initiation date
Apr 26, 2022
Center classification date
Jun 30, 2022
Termination date
Mar 15, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records